Enabling innovation in cell and gene therapy

Expertise

In the news

Development
of new ATMPS

Lentiviral vector production

Visitez l'ART-TG pour la fête de la science 2021

https://www.youtube.com/watch?v=6jzlHz2Vbrw

Artificial Intelligence to improve the bioproduction of lentiviral gene therapy vectors.

ART-TG is pleased to announce its collaboration with WhiteLab Genomics on the development of artificial intelligence to improve the...

SEE MORE INFORMATION

About us

ART-TG is an innovation and development laboratory for cell and gene therapy, established by Inserm. Its mission is to accelerate the transfer of promising research discoveries towards clinical stages, which ultimately will ensure that the best gene therapies will be available for patients.

Anne Galy, founder of ART-TG (view her bio)

ART-TG is a founding member of the MAGENTA industrial integrator, established by the French government to address the challenges of industrial production of biomedecines.